Experts are cautioning against prescribing an experimental drug that has never been tested in humans.
The drug, called ZMapp, has been on the market since March, but is still not approved by the Food and Drug Administration, which oversees the drug industry.
The FDA says the drug’s safety is unknown and has not tested it in humans yet.
And experts say there is not much data on its efficacy in treating the disease.
They also say it is not yet clear what the potential side effects might be and it is unclear how much of a benefit the drug could provide.
In Indiana, ZMopp is not the only drug that is not approved.
Experts also caution against the use of drugs that do not have proven safety and efficacy in humans, saying that they are not worth the risk of side effects and they should not be used in people who have already been infected.
Eric Holcomb has said that he supports the FDA’s decision to approve the drug.
ZMamp will be used to treat patients with a weakened immune system.
The medicine, which is manufactured by a company called Genentech, was approved in the U.S. for treating patients with severe diarrhea and vomiting who have been diagnosed with Ebola.
It is now being tested in patients with other severe conditions, such as multiple sclerosis and epilepsy.
The company has received more than $1.6 billion in funding.
A spokesperson for Genentec said the company has been testing ZMop for more than a year in clinical trials in the United States.
The Drug Enforcement Administration says the company tested ZMomp in the European Union.
The European Food Safety Authority said the drug is safe and effective.
And the U-Kan Health Department said the Uptake program for ZMep has been successful and has proven to be effective.
The U.K. has the highest number of Ebola cases per capita of any country in the world, and there have been more than 100 confirmed cases in the country, according to the World Health Organization.
Indiana has about 1,100 registered residents, but the state has only 10 registered nurse practitioners and a total of 1,400 health care workers.